Selected article for: "broad spectrum and immune cell"

Author: He, Sijia; Waheed, Abdul A.; Hetrick, Brian; Dabbagh, Deemah; Akhrymuk, Ivan V.; Kehn-Hall, Kylene; Freed, Eric O.; Wu, Yuntao
Title: PSGL-1 inhibits the virion incorporation of SARS-CoV and SARS-CoV-2 spike glycoproteins and impairs virus attachment and infectivity
  • Cord-id: gmy9zyad
  • Document date: 2020_7_6
  • ID: gmy9zyad
    Snippet: P-selectin glycoprotein ligand-1 (PSGL-1) is a cell surface glycoprotein that binds to P-, E-, and L-selectins to mediate the tethering and rolling of immune cells on the surface of the endothelium for cell migration into inflamed tissues. PSGL-1 has been identified as an interferon-γ (INF-γ)-regulated factor that restricts HIV-1 infectivity, and has recently been found to possess broad-spectrum antiviral activities. Here we report that the expression of PSGL-1 in virus-producing cells impairs
    Document: P-selectin glycoprotein ligand-1 (PSGL-1) is a cell surface glycoprotein that binds to P-, E-, and L-selectins to mediate the tethering and rolling of immune cells on the surface of the endothelium for cell migration into inflamed tissues. PSGL-1 has been identified as an interferon-γ (INF-γ)-regulated factor that restricts HIV-1 infectivity, and has recently been found to possess broad-spectrum antiviral activities. Here we report that the expression of PSGL-1 in virus-producing cells impairs the incorporation of SARS-CoV and SARS-CoV-2 spike (S) glycoproteins into pseudovirions and blocks virus attachment and infection of target cells. These findings suggest that PSGL-1 may potentially inhibit coronavirus replication in PSGL-1+ cells.

    Search related documents:
    Co phrase search for related documents
    • absence presence and adaptive immunity: 1, 2, 3, 4
    • absence presence and luciferase reporter: 1, 2, 3, 4, 5
    • absence presence and lung cancer: 1, 2, 3, 4
    • absence presence and lung cancer cell: 1
    • adaptive immunity and lung cancer: 1, 2, 3, 4
    • luc background and luciferase reporter: 1
    • luc expression and luciferase reporter: 1, 2, 3, 4, 5, 6
    • luciferase reporter and lung cancer: 1, 2, 3, 4, 5
    • luciferase reporter and lung target cell: 1